Practically speaking, does biosimilar interchangeability matter today

AMCP Volunteer Spotlight: Matt Moen

AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Matt Moen, PharmD, MBA, AMCP Membership Committee member.   
AMCP Membership
AMCP Podcast Series Featured Episode

Unpacking the CMS Guidance on Drug Negotiation, Part 2

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
AMCP Podcast Series Featured Episode

Unpacking the CMS Guidance on Drug Negotiation, Part 1

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
AMCP Regulatory NewsBreaks

April 6, 2023: CMS Issues Medicare Advantage, Part D, and PACE Final Rule

On April 5, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a Final Rule, titled “Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly” (Final Rule).